There may be real-world data (RWD) available when there is no trial data that compares a medicine of interest to a comparator of interest. In this case, it may be possible to use this RWD to enable an indirect comparison treatment comparison or network meta-analysis (NMA).
For more information on evidence synthesis and NMA, including information on best practice, see here.